OTCMKTS:SDMHF Sartorius Stedim Biotech (SDMHF) Stock Price, News & Analysis $218.00 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort Interest About Sartorius Stedim Biotech Stock (OTCMKTS:SDMHF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SDMHF alerts:Sign Up Key Stats Today's Range$218.00▼$218.0050-Day Range$195.00▼$236.5052-Week Range$158.00▼$299.86Volume20,000 shsAverage Volume1,478 shsMarket CapitalizationN/AP/E Ratio50.58Dividend Yield0.55%Price TargetN/AConsensus RatingN/A Company OverviewSartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.Read More… Receive SDMHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address SDMHF Stock News HeadlinesBoard of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ MeetingFebruary 7, 2025 | markets.businessinsider.comKepler Capital Sticks to Its Hold Rating for Sartorius Stedim Biotech (0RG8)January 31, 2025 | markets.businessinsider.comWill Trump's Tariffs send this AL stock soaring?If you missed out on Nvidia's massive surge... Don't worry. Because Trump's new tariffs just set the stage for an even bigger AI opportunity.February 24, 2025 | Behind the Markets (Ad)Sartorius Stedim Biotech SA (SDMHF) Q4 2024 Earnings Call Highlights: Navigating Growth Amid ...January 31, 2025 | finance.yahoo.comSartorius Stedim Biotech (0RG8) Receives a Buy from JefferiesJanuary 30, 2025 | markets.businessinsider.comGoldman Sachs Keeps Their Buy Rating on Sartorius Stedim Biotech (0RG8)January 30, 2025 | markets.businessinsider.comSartorius, Sartorius Stedim Biotech shares jump after results beatJanuary 28, 2025 | reuters.comSartorius Stedim Biotech (0RG8) Gets a Buy from RBC CapitalDecember 11, 2024 | markets.businessinsider.comSee More Headlines SDMHF Stock Analysis - Frequently Asked Questions How have SDMHF shares performed this year? Sartorius Stedim Biotech's stock was trading at $195.00 on January 1st, 2025. Since then, SDMHF shares have increased by 11.8% and is now trading at $218.00. View the best growth stocks for 2025 here. How do I buy shares of Sartorius Stedim Biotech? Shares of SDMHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today2/24/2025Next Earnings (Estimated)4/16/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:SDMHF CUSIPN/A CIKN/A Webwww.sartorius.com Phone(344) 284-5600FaxN/AEmployees10,382Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio50.58 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (OTCMKTS:SDMHF) was last updated on 2/24/2025 by MarketBeat.com Staff From Our PartnersMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in FebruaryTrump’s World Liberty Bought $1M of THIS Coin Early investors could reap HUGE benefits…Crypto 101 Media | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryA little-known IRS loophole has been gaining serious attention... If you have a retirement account, you can...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sartorius Stedim Biotech S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sartorius Stedim Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.